(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 36.07%33.2M | -23.85%104.42M | -31.52%25.16M | -23.40%28.63M | -22.13%26.23M | -16.81%24.4M | 63.07%137.13M | 29.62%36.75M | 91.41%37.38M | 73.60%33.68M |
Net income from continuing operations | -9.71%14.92M | -13.29%66.14M | -6.37%18.56M | -19.27%15.34M | -25.11%15.72M | 0.35%16.53M | -15.21%76.28M | -62.67%19.82M | 55.85%19M | 60.79%20.99M |
Operating gains losses | 117.89%22K | 741.67%308K | 514.71%282K | 101.52%6K | -64.52%143K | -1,218.18%-123K | 99.88%-48K | 99.82%-68K | 60.08%-394K | 150.25%403K |
Depreciation and amortization | 9.43%18.34M | 5.74%68.15M | 5.26%17.32M | 4.86%17.25M | 4.75%16.82M | 8.19%16.76M | 50.88%64.45M | 20.26%16.46M | 60.47%16.45M | 55.25%16.06M |
Remuneration paid in stock | 81.33%408K | -28.67%928K | -15.27%283K | -35.71%207K | -33.85%213K | -30.34%225K | -30.09%1.3M | -28.78%334K | -30.60%322K | -19.90%322K |
Deferred tax | -12.46%-2.07M | -116.58%-4.43M | -136.44%-649K | -68.64%-683K | 25.59%-1.26M | -6.30%-1.84M | 29.36%-2.05M | 220.34%1.78M | 28.45%-405K | -309.69%-1.69M |
Other non cashItems | -44.78%37K | -2.60%262K | -10.29%61K | 0.00%67K | 0.00%67K | 0.00%67K | 11.16%269K | 1.49%68K | 0.00%67K | 0.00%67K |
Change In working capital | 121.22%1.53M | -775.78%-26.94M | -548.57%-10.7M | -251.09%-3.55M | -122.11%-5.48M | -451.80%-7.22M | 56.99%-3.08M | -269.48%-1.65M | 224.38%2.35M | 24.11%-2.47M |
-Change in receivables | 178.10%2.28M | -43.92%-4.11M | -1,267.17%-3.09M | -239.77%-3.51M | 175.58%5.42M | -290.18%-2.92M | 79.87%-2.86M | 120.88%265K | 131.45%2.51M | -318.51%-7.17M |
-Change in inventory | 109.47%25K | -534.38%-2.01M | -1,531.15%-995K | -335.98%-715K | -110.31%-37K | 41.46%-264K | 32.84%-317K | 84.07%-61K | -29.13%-164K | -42.28%359K |
-Change in payables and accrued expense | -121.13%-1.6M | -7,983.55%-18.67M | -164.01%-9.29M | 353.22%2.67M | -368.79%-11.34M | 52.37%-724K | -103.03%-231K | -297.64%-3.52M | -89.34%590K | 256.77%4.22M |
-Change in other working capital | 124.94%826K | -756.27%-2.15M | 61.02%2.68M | -237.39%-1.99M | 274.22%479K | -278.51%-3.31M | 370.25%327K | 97.04%1.67M | -185.40%-591K | -75.98%128K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 36.07%33.2M | -23.85%104.42M | -31.52%25.16M | -23.40%28.63M | -22.13%26.23M | -16.81%24.4M | 63.07%137.13M | 29.62%36.75M | 91.41%37.38M | 73.60%33.68M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -50.36%-8.03M | 47.65%-23.85M | 27.33%-7.94M | 23.68%-5.45M | -155.54%-5.12M | 79.05%-5.34M | 75.16%-45.56M | 88.25%-10.93M | -385.44%-7.14M | 27.94%-2M |
Net PPE purchase and sale | -59.46%-7.7M | 9.36%-21.78M | 30.95%-7.13M | 21.06%-5.16M | -16.01%-4.66M | -53.48%-4.83M | -209.31%-24.03M | -286.20%-10.32M | -431.87%-6.54M | -65.04%-4.02M |
Net intangibles purchas and sale | 35.28%-332K | 6.46%-2.07M | -34.38%-813K | 52.53%-282K | 0.65%-461K | 6.56%-513K | -34.71%-2.21M | 7.21%-605K | -147.50%-594K | -36.07%-464K |
Net business purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | 88.90%-19.32M | --0 | --0 | 41,383.33%2.48M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -50.36%-8.03M | 47.65%-23.85M | 27.33%-7.94M | 23.68%-5.45M | -155.54%-5.12M | 79.05%-5.34M | 75.16%-45.56M | 88.25%-10.93M | -385.44%-7.14M | 27.94%-2M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -65.99%-17.41M | -67.06%-86.18M | -149.88%-25.26M | -296.05%-39.66M | 61.34%-10.77M | -190.12%-10.49M | -154.94%-51.59M | -113.46%-10.11M | 45.51%-10.02M | -3.49%-27.85M |
Net issuance payments of debt | -0.18%-7.18M | -32.27%-52.95M | 3.31%-7.1M | -331.26%-31.72M | 72.50%-6.96M | -59,658.33%-7.17M | -467.59%-40.03M | 53.49%-7.35M | 57.36%-7.35M | -0.40%-25.32M |
Net common stock issuance | ---6.28M | ---18.84M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Cash dividends paid | -23.23%-4.13M | -30.50%-14.2M | -27.20%-3.73M | -28.43%-3.76M | -33.63%-3.35M | -33.64%-3.35M | -38.57%-10.88M | -40.85%-2.93M | -52.29%-2.93M | -30.46%-2.51M |
Net other financing activities | 422.22%188K | 71.94%-188K | 2,495.29%4.41M | -1,656.13%-4.19M | -2,900.00%-450K | 103.29%36K | 89.19%-670K | 104.64%170K | -65.95%269K | 84.54%-15K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -65.99%-17.41M | -67.06%-86.18M | -149.88%-25.26M | -296.05%-39.66M | 61.34%-10.77M | -190.12%-10.49M | -154.94%-51.59M | -113.46%-10.11M | 45.51%-10.02M | -3.49%-27.85M |
Net cash flow | ||||||||||
Beginning cash position | -9.29%59.74M | 163.53%65.86M | 34.73%68.29M | 187.79%84.27M | 196.94%74.4M | 163.53%65.86M | -17.11%24.99M | 254.10%50.68M | 100.08%29.28M | 0.52%25.05M |
Current changes in cash | -9.45%7.76M | -114.03%-5.61M | -151.19%-8.04M | -181.45%-16.48M | 170.11%10.34M | 3,776.92%8.57M | 840.17%39.98M | 50.55%15.71M | 6,401.87%20.23M | 137.19%3.83M |
Effect of exchange rate changes | 2,544.44%660K | -157.21%-504K | 5.61%-505K | -57.75%496K | -217.29%-468K | 82.80%-27K | 261.07%881K | -319.26%-535K | --1.17M | --399K |
End cash Position | -8.38%68.16M | -9.29%59.74M | -9.29%59.74M | 34.73%68.29M | 187.79%84.27M | 196.94%74.4M | 163.53%65.86M | 163.53%65.86M | 254.10%50.68M | 100.08%29.28M |
Free cash from | 33.27%24.89M | -27.79%78.83M | -33.43%16.72M | -21.67%22.89M | -29.64%20.54M | -27.14%18.67M | 46.69%109.17M | 1.28%25.12M | 62.12%29.22M | 75.62%29.2M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.